Table 5.
Same as in Table 4 except the control is a one-week lag.
Smoother | Lag | Category | Mean Difference | Significance | 5% C.I. | 95% C.I. |
---|---|---|---|---|---|---|
No | No | Total | 5.7 | 0.003 | 2.2 | 9.1 |
Female | 2.6 | 0.040 | −0.3 | 5.1 | ||
Male | 3.0 | 0.019 | 0.3 | 5.6 | ||
Black | 2.2 | 0.025 | 0.2 | 4.2 | ||
White | 3.6 | 0.017 | 0.2 | 6.7 | ||
Age 20–29 | 1.4 | 0.038 | −0.1 | 2.8 | ||
Age 30–49 | 2.9 | 0.005 | 0.8 | 5.0 | ||
Endocrine | 1.1 | 0.001 | 0.5 | 1.7 | ||
Congenital | 0.1 | 0.049 | 0.0 | 0.2 | ||
Injuries | 1.4 | 0.046 | −0.1 | 3.0 | ||
Other | 1.3 | 0.028 | 0.2 | 2.5 | ||
1-day | Age 30–49 | 2.9 | 0.008 | 0.5 | 5.1 | |
3-day MA | No | Total | 4.8 | 0.003 | 1.3 | 8.2 |
Female | 2.3 | 0.050 | −0.2 | 5.0 | ||
Male | 2.5 | 0.028 | 0.1 | 5.0 | ||
Black | 1.8 | 0.035 | −0.1 | 3.7 | ||
White | 3.2 | 0.021 | 0.3 | 6.1 | ||
Age 20–29 | 1.3 | 0.022 | 0.1 | 2.5 | ||
Age 30–49 | 3.1 | 0.001 | 1.3 | 4.7 | ||
Endocrine | 0.8 | 0.003 | 0.3 | 1.3 | ||
Congenital | 0.1 | 0.036 | 0.0 | 0.2 | ||
Other | 1.1 | 0.014 | 0.3 | 2.0 | ||
1-day | Total | 4.2 | 0.045 | 0.1 | 9.0 | |
Male | 2.7 | 0.036 | 0.0 | 5.7 | ||
White | 3.1 | 0.042 | −0.1 | 6.3 | ||
Age 30–49 | 2.5 | 0.012 | 0.6 | 4.5 | ||
Endocrine | 0.7 | 0.020 | 0.1 | 1.2 |